Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment
Oncogene, Published online: 04 January 2024; doi:10.1038/s41388-023-02918-wLoss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment (Source: Oncogene)
Source: Oncogene - January 4, 2024 Category: Cancer & Oncology Authors: Chin-Jui Wu Ke-Fan Pan Ji-Qing Chen Yu -Chen Tao Yu-Cheng Liu Bo-Rong Chen Ching Hsu Ming-Yang Wang Bor-Ching Sheu Michael Hsiao Kuo-Tai Hua Lin-Hung Wei Source Type: research
Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway
Oncogene, Published online: 04 January 2024; doi:10.1038/s41388-023-02912-2Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway (Source: Oncogene)
Source: Oncogene - January 4, 2024 Category: Cancer & Oncology Authors: Xiaobo Luo Yan Qiu Zackary R. Fitzsimonds Qiuhao Wang Qianming Chen Yu Leo Lei Source Type: research
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis
Oncogene, Published online: 02 January 2024; doi:10.1038/s41388-023-02923-zThe Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis (Source: Oncogene)
Source: Oncogene - January 2, 2024 Category: Cancer & Oncology Authors: Xiaofeng Zhou Ziyi Yan Jinghan Hou Lichen Zhang Zhen Chen Can Gao Nor Hazwani Ahmad Mingzhou Guo Weilong Wang Tao Han Tingmin Chang Xiaohong Kang Lidong Wang Yinming Liang Xiumin Li Source Type: research
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target
Oncogene, Published online: 23 December 2023; doi:10.1038/s41388-023-02925-xMyeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target (Source: Oncogene)
Source: Oncogene - December 23, 2023 Category: Cancer & Oncology Authors: Marina G. Ferrari Alexis P. Jimenez-Uribe Li Wang Luke H. Hoeppner Paari Murugan Eunsil Hahm Jindan Yu Timothy M. Kuzel Sergio A. Gradilone Adrian P. Mansini Source Type: research
ERRα: unraveling its role as a key player in cell migration
Oncogene, Published online: 21 December 2023; doi:10.1038/s41388-023-02899-wERRα: unraveling its role as a key player in cell migration (Source: Oncogene)
Source: Oncogene - December 21, 2023 Category: Cancer & Oncology Authors: Jean-Marc Vanacker Christelle Forcet Source Type: research
TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC
Oncogene, Published online: 20 December 2023; doi:10.1038/s41388-023-02922-0TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC (Source: Oncogene)
Source: Oncogene - December 20, 2023 Category: Cancer & Oncology Authors: Jingtian Yu Mingxing Li Lingao Ju Fenfang Zhou Yejinpeng Wang Yi Zhang Renjie Zhang Wenzhi Du Ruoyu Huang Kaiyu Qian Gang Wang Yu Xiao Xinghuan Wang Source Type: research
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia
Oncogene, Published online: 16 December 2023; doi:10.1038/s41388-023-02921-1USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia (Source: Oncogene)
Source: Oncogene - December 16, 2023 Category: Cancer & Oncology Authors: Hu Lei Hanzhang Xu Li Yang Yingying Wang Youping Zhang Yingli Wu Source Type: research
Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia
Oncogene, Published online: 15 December 2023; doi:10.1038/s41388-023-02913-1Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia (Source: Oncogene)
Source: Oncogene - December 15, 2023 Category: Cancer & Oncology Authors: Mina Noura Hidemasa Matsuo Takahiko Yasuda Shinobu Tsuzuki Hitoshi Kiyoi Fumihiko Hayakawa Source Type: research
SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma
Oncogene, Published online: 15 December 2023; doi:10.1038/s41388-023-02917-xSOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma (Source: Oncogene)
Source: Oncogene - December 15, 2023 Category: Cancer & Oncology Authors: Shujun Han Mo Zhang Xiaoyan Qu Zihao Wu Zongguan Huang Yiming Hu Ying Li Lanlan Cui Lu Si Jiankang Liu Yongping Shao Source Type: research
Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
Oncogene, Published online: 14 December 2023; doi:10.1038/s41388-023-02920-2Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression (Source: Oncogene)
Source: Oncogene - December 14, 2023 Category: Cancer & Oncology Authors: Karina A. Miller Seamus Degan Yanqing Wang Joseph Cohen Sheng Yu Ku David W. Goodrich Irwin H. Gelman Source Type: research
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer
Oncogene, Published online: 14 December 2023; doi:10.1038/s41388-023-02914-0PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer (Source: Oncogene)
Source: Oncogene - December 14, 2023 Category: Cancer & Oncology Authors: Shailender S. Chauhan Andrea L. Casillas Andres D. Vizzerra Hope Liou Amber N. Clements Caitlyn E. Flores Christopher T. Prevost David F. Kashatus Ashley J. Snider Justin M. Snider Noel A. Warfel Source Type: research
RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression
Oncogene, Published online: 14 December 2023; doi:10.1038/s41388-023-02910-4RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression (Source: Oncogene)
Source: Oncogene - December 14, 2023 Category: Cancer & Oncology Authors: Xiao Yu Pengfei Zhao Qingyu Luo Xiaowei Wu Yating Wang Yabing Nan Shi Liu Wenyan Gao Bin Li Zhihua Liu Zhumei Cui Source Type: research
From odor to oncology: non-canonical odorant receptors in cancer
Oncogene, Published online: 12 December 2023; doi:10.1038/s41388-023-02908-yFrom odor to oncology: non-canonical odorant receptors in cancer (Source: Oncogene)
Source: Oncogene - December 12, 2023 Category: Cancer & Oncology Authors: Sung Jin Park Paul L. Greer Namgyu Lee Source Type: research
The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention
Oncogene, Published online: 11 December 2023; doi:10.1038/s41388-023-02909-xThe nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention (Source: Oncogene)
Source: Oncogene - December 11, 2023 Category: Cancer & Oncology Authors: Yang Lyu Fuda Xie Bonan Chen Wing Sum Shin Wei Chen Yulong He Kam Tong Leung Gary M. K. Tse Jun Yu Ka Fai To Wei Kang Source Type: research
ROS production by mitochondria: function or dysfunction?
Oncogene, Published online: 11 December 2023; doi:10.1038/s41388-023-02907-zROS production by mitochondria: function or dysfunction? (Source: Oncogene)
Source: Oncogene - December 11, 2023 Category: Cancer & Oncology Authors: Flavio R. Palma Benjamin N. Gantner Marcelo J. Sakiyama Cezar Kayzuka Sanjeev Shukla Riccardo Lacchini Brian Cunniff Marcelo G. Bonini Source Type: research
